Advanced Technical Precision: Utilizes Fluorescence Immunochromatography Assay (FIA) for highly sensitive, precise quantitative results with zero cross-reactivity.
Certified Quality Compliance: Manufactured under strict international standards, fully compliant with CE and ISO13485 certifications.
Premium After-Sales & Warranty: Features a 2-year long-term warranty alongside professional online usage guidance and quality support.
Product Introduction Copy (Marketing Copy)
["The 'Gold Standard' Triad Approach for Myocardial Infarction Diagnosis - Fast, Accurate, Quantitative"]
In the treatment of acute myocardial infarction (AMI), time is of the essence. (Guogao Biotech) The cTnI/CK-MB/MYO tri-enzyme detection kit uses advanced fluorescence immunochromatography technology (FIA) to simultaneously quantify the three core markers of myocardial injury on a single test card, providing an efficient and reliable auxiliary diagnostic solution for emergency departments, cardiology departments, and chest pain centers.
Core Strengths
"Trinity" Collaborative Diagnosis:
MYO (Myoglobin): The earliest to appear (1-2 hours), with extremely high negative predictive value, used for early screening.
cTnI (Troponin I): The most tissue-specific, it is the "gold standard" for diagnosing myocardial injury.
CK-MB (Creatine Kinase Isoenzyme): The window period is moderate, and it has significant reference value for judging myocardial re-infarction.
Fluorescence Quantification, Precise Results: Compared with traditional colloidal gold qualitative detection, the fluorescence method provides precise numerical results, with a wide linear range, high sensitivity, and can capture more subtle myocardial damage signals.
15-minute Emergency Response: After sampling, a quantitative report for the three tests can be obtained within 15 minutes, significantly shortening the D-to-N (from arrival at the hospital to administration) time.
Full Sample Compatibility, POCT Preferred: Compatible with whole blood, serum, and plasma. Measured bedside, no need for complex laboratory pre-treatment, suitable for emergency and mobile medical scenarios.
Quality Compliance: Produced by Hebei Guo Gao Biotechnology, strictly following the ISO13485 quality system, equipped with a dedicated fluorescence immunoassay instrument, achieving intelligent interpretation.
Product Specifications
| Brand | Guogao Biotech |
| Product Name | cTnI / CK-MB / MYO Cardiac Triplex Combination Assay Kit |
| Methodology | Fluorescence Immunochromatography |
| Test Type | Quantitative Determination |
| Clinical Use | Diagnosis of Acute Myocardial Infarction (AMI), Differential diagnosis of chest pain, Monitoring of myocardial injury |
| Specimen | Whole Blood / Serum / Plasma |
| Linear Range (cTnI) | Typically 0.1 – 50.0 ng/mL |
| Linear Range (CK-MB) | Typically 1.0 – 100.0 ng/mL |
| Linear Range (MYO) | Typically 5.0 – 500.0 ng/mL |
| Reaction Time | 15 minutes |
| Storage Condition | 2°C – 30°C (Store at room temperature, protect from direct sunlight) |
| Shelf Life | 24 months |
| Required Equipment | Compatible with a dedicated fluorescence immunoanalyzer for result reading |
Place of Origin: |
China,Hebei |
Brand Name: |
GuoGao |
Model Number: |
CK-MB |
Certification: |
CE ISO13485 |
The Hospital Lab Use High Sensitive CK-MB Diagnostic Test Kit POCT Immunoassay Analyzer Rapid Test Kits for Human by Beijing Jiachuang Jiuhe Global Trade Co., Ltd is a professional-grade, quantitative cardiac biomarker rapid test. Designed for critical care environments, this CK-MB diagnostic test kit works seamlessly with a POCT immunoassay analyzer to provide highly sensitive results within 10 to 15 minutes. It enables rapid clinical decisions during acute cardiac events. Manufactured under strict international standards, these rapid test kits for human use offer global hospital labs, distributors, and B2B medical buyers a reliable, lab-accurate solution for identifying early-stage myocardial damage.
In emergency medicine, timing is everything. Our CK-MB diagnostic test kit serves as a vital diagnostic tool for the early detection and monitoring of acute myocardial infarction (AMI). Creatine Kinase-MB (CK-MB) remains an essential clinical marker due to its rapid rise following myocardial injury and its specific correlation to cardiac tissue damage. This specialized rapid test kits for human health monitoring is engineered to deliver highly sensitive quantitative data when paired with an advanced POCT immunoassay analyzer.
Quantitative POCT Compatibility: Fully optimized for precise data collection using a fluorescence POCT immunoassay analyzer.
Rapid Turnaround Time: Delivers highly accurate quantitative results in 10-15 minutes, crucial for emergency room cardiac screening.
High Sensitivity Assay: Detects low-level elevations of CK-MB to assist in early acute myocardial infarction diagnostic workflows.
Flexible Sample Matrix: Supports multiple specimen types including human whole blood, serum, and plasma without complex preprocessing.
Long-Term Storage Stability: Features individually sealed foil pouches with desiccant, ensuring an extended shelf life of up to 24 months.
As a trusted provider of wholesale CK-MB test kits, we maintain transparent parameters required for international medical tenders and hospital procurement:
| Parameter | Specification Detail |
| Product Name | High Sensitive CK-MB Diagnostic Test Kit |
| Testing Methodology | Fluorescence Immunochromatography Assay |
| Compatible Device | Quantitative POCT Immunoassay Analyzer |
| Specimen Requirements | Whole Blood / Serum / Plasma |
| Linear Detection Range | 1.0 ng/mL – 100.0 ng/mL |
| Analytical Sensitivity | ≤ 1.0 ng/mL |
| Reaction Time | 10 to 15 Minutes |
| Storage Temperature | 4°C – 30°C (Do not freeze) |
| Kit Packaging Sizes | 10, 25, or 50 test cassettes per retail box |
From an immunological standpoint, our CK-MB diagnostic test kit utilizes a sophisticated fluorescence-labeled double-antibody sandwich technique. The test strip inside the cassette contains a nitrocellulose membrane pre-coated with anti-CK-MB monoclonal antibodies on the test line (T) and control antibodies on the control line (C).
During testing, the CK-MB in the human specimen binds to a fluorescently conjugated anti-CK-MB antibody. As the mixture flows along the membrane, it is captured by the immobilized antibodies on the T-line. When inserted into the POCT immunoassay analyzer, a laser scans the test line. The intensity of the fluorescence signal directly corresponds to the concentration of CK-MB in the sample.
Many standard rapid test kits for human clinical use suffer from cross-reactivity with skeletal muscle-derived CK-MM. Our advanced manufacturing process uses ultra-purified monoclonal antibodies specifically targeted to the conformational epitope of the MB dimer, successfully eliminating cross-reactivity and ensuring a highly reliable acute myocardial infarction diagnostic path.
Hospital Emergency Rooms & ICUs: Enables on-site, point-of-care testing to accelerate cardiac triage protocols.
Clinical & Commercial Laboratories: Acts as an efficient backup or primary automated cardiac biomarker rapid test system for mid-to-high throughput demands.
Medical Equipment Distributors: An essential product addition for global B2B medical companies supplying wholesale CK-MB test kits to regional healthcare systems.
Partnering with Beijing Jiachuang Jiuhe Global Trade Co., Ltd as your POCT diagnostic kit manufacturer offers significant financial advantages. Cardiovascular diagnostics represent one of the fastest-growing sectors in the global IVD (In Vitro Diagnostics) market. Hospital and laboratory demands for high-quality, cost-effective rapid test kits for human assessment are constantly rising.
By integrating our CK-MB diagnostic test kit into your distribution pipeline, B2B procurement managers can maximize their competitive edge. Our competitive factory pricing allows distributors to secure healthy profit margins while offering healthcare facilities lower per-test costs compared to expensive central laboratory chemical assays. This high-margin, high-turnover product model ensures consistent reorders and long-term business stability.
No, this specific CK-MB diagnostic test kit is designed exclusively for quantitative measurement. It must be read using a compatible POCT immunoassay analyzer to guarantee accurate numerical results for professional clinical assessment.
Our standard minimum order quantity (MOQ) for global distributors is 500 boxes. As a comprehensive POCT diagnostic kit manufacturer, we offer full OEM and private label services, including custom box printing and multi-lingual documentation.
Advanced Technical Precision: Utilizes Fluorescence Immunochromatography Assay (FIA) for highly sensitive, precise quantitative results with zero cross-reactivity.
Certified Quality Compliance: Manufactured under strict international standards, fully compliant with CE and ISO13485 certifications.
Premium After-Sales & Warranty: Features a 2-year long-term warranty alongside professional online usage guidance and quality support.
EN